Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 437
6
Diseases
7
Unique genes
0.333
Avg. similarity score
Menkes disease
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Menkes disease
Neuronopathy, distal hereditary motor, x-linked
Occipital horn syndrome
X-linked distal spinal muscular atrophy
Aortic rupture
Au-kline syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Menkes disease | 5 | 5 | 1 |
| Neuronopathy, distal hereditary motor, x-linked | 5 | 5 | 1 |
| Occipital horn syndrome | 5 | 5 | 1 |
| X-linked distal spinal muscular atrophy | 5 | 5 | 1 |
| Aortic rupture | 4 | 4 | 5 |
| Au-kline syndrome | 4 | 4 | 3 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ATP7A | 6 / 6 | Aortic rupture, Au-kline syndrome, Menkes disease, Neuronopathy, distal hereditary motor, x-linked and 2 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Degradation of the extracellular matrix | Reactome | 3 / 70 | 73.5× | 6.53e-6 | 2.04e-4 ✓ sig. |
| Activation of Matrix Metalloproteinases | Reactome | 2 / 33 | 104× | 1.52e-4 | 2.65e-3 ✓ sig. |
| Bladder cancer | KEGG | 2 / 41 | 83.7× | 2.36e-4 | 3.74e-3 ✓ sig. |
| EPH-ephrin mediated repulsion of cells | Reactome | 2 / 50 | 68.6× | 3.52e-4 | 5.09e-3 ✓ sig. |
| Collagen degradation | Reactome | 2 / 52 | 66.0× | 3.81e-4 | 5.41e-3 ✓ sig. |
| Extra-nuclear estrogen signaling | Reactome | 2 / 58 | 59.2× | 4.74e-4 | 6.41e-3 ✓ sig. |
| Endocrine resistance | KEGG | 2 / 99 | 34.7× | 1.38e-3 | 1.44e-2 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 2 / 108 | 31.8× | 1.63e-3 | 1.64e-2 ✓ sig. |
| Metabolism of vitamin K | Reactome | 1 / 3 | 572× | 1.75e-3 | 1.73e-2 ✓ sig. |
| Leukocyte transendothelial migration | KEGG | 2 / 116 | 29.6× | 1.88e-3 | 1.82e-2 ✓ sig. |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | Reactome | 2 / 125 | 27.5× | 2.18e-3 | 2.03e-2 ✓ sig. |
| Ion influx/efflux at host-pathogen interface | Reactome | 1 / 4 | 429× | 2.33e-3 | 2.13e-2 ✓ sig. |
| Relaxin signaling pathway | KEGG | 2 / 130 | 26.4× | 2.36e-3 | 2.15e-2 ✓ sig. |
| Pathways in cancer | KEGG | 3 / 533 | 9.7× | 2.66e-3 | 2.34e-2 ✓ sig. |
| Estrogen signaling pathway | KEGG | 2 / 139 | 24.7× | 2.69e-3 | 2.36e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cellular response to UV-A | GO:0071492 | 2 / 11 | 485× | 6.60e-6 | 3.94e-4 ✓ sig. |
| response to amyloid-beta | GO:1904645 | 2 / 15 | 356× | 1.26e-5 | 6.50e-4 ✓ sig. |
| extracellular matrix organization | GO:0030198 | 3 / 145 | 55.2× | 1.57e-5 | 7.70e-4 ✓ sig. |
| endodermal cell differentiation | GO:0035987 | 2 / 36 | 148× | 7.53e-5 | 2.51e-3 ✓ sig. |
| collagen catabolic process | GO:0030574 | 2 / 41 | 130× | 9.79e-5 | 3.04e-3 ✓ sig. |
| extracellular matrix disassembly | GO:0022617 | 2 / 47 | 114× | 1.29e-4 | 3.71e-3 ✓ sig. |
| embryo implantation | GO:0007566 | 2 / 48 | 111× | 1.35e-4 | 3.82e-3 ✓ sig. |
| lung alveolus development | GO:0048286 | 2 / 49 | 109× | 1.40e-4 | 3.94e-3 ✓ sig. |
| ephrin receptor signaling pathway | GO:0048013 | 2 / 51 | 105× | 1.52e-4 | 4.19e-3 ✓ sig. |
| positive regulation of vascular associated smooth muscle cell proliferation | GO:1904707 | 2 / 53 | 101× | 1.64e-4 | 4.41e-3 ✓ sig. |
| negative regulation of cation transmembrane transport | GO:1904063 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| negative regulation of epithelial cell differentiation involved in kidney development | GO:2000697 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | GO:1902165 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| negative regulation of apoptotic process | GO:0043066 | 3 / 524 | 15.3× | 7.05e-4 | 1.19e-2 ✓ sig. |
| activation of protein kinase A activity | GO:0034199 | 1 / 2 | 1,335× | 7.49e-4 | 1.23e-2 ✓ sig. |